Trump’s FDA Nominee Faces Uphill Battle Amidst Growing Concerns Over Estrogen Patch Shortages and Regulatory Shifts.
As the summer of 2026 enters its final weeks, the intersection of high-stakes federal politics...
As the summer of 2026 enters its final weeks, the intersection of high-stakes federal politics...
The appointment of Adrian Quartel, M.D., to the helm of Spruce Biosciences’ medical strategy marks...
The Trump administration, in tandem with Health and Human Services Secretary Robert F. Kennedy Jr.,...
In a move that signals a seismic shift in the federal government’s approach to public...
The Trump administration, led by Health and Human Services (HHS) Secretary Robert F. Kennedy Jr.,...
The prospect of a definitive cure for HIV stands as one of the most anticipated...
The selection of Heidi Overton to lead the Food and Drug Administration (FDA) marks a...
At the heart of this transition was Kyle Diamantas, the acting FDA commissioner who had...
To understand the skepticism surrounding Capricor’s current strategy, one must look at the nature of...
The selection of Dr. Heidi Overton to serve as the Commissioner of the Food and...